Laplace Interventional
Plymouth, US · Founded 2020 · 3 known investors
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
HealthtechMedical Devices
Founders & leadership
Laplace Interventional was founded in 2020 by Ramji Iyer.
RI
Ramji IyerFounder
Board
JH
Jenny H. BarbaBoard director
TM
Todd MortierBoard director
CM
Colin MorrisonBoard director
Investors · 3
Competitors · 5
by search overlapMassdevice6 shared keywordsMassDevice is a news and media outlet covering the medical device industry, publishing articles, special reports, and white papers on medtech companies, products, and regulatory topics such as FDA 510(k) submissions. It serves medical device professionals with industry news and analysis.
Edwards Lifesciences5 shared keywords
Rf Surgical5 shared keywordsMedtronic develops healthcare technology, including pulsed field ablation systems used to treat atrial fibrillation (AFib). The company serves clinicians and healthcare providers in the medical device and cardiac care field.
Vumedi4 shared keywordsVumedi operates a peer-to-peer video education platform where clinicians watch lectures and technique videos across dozens of medical specialties. It partners with academic institutions, hospitals, and life sciences companies to provide continuing medical education content to doctors.
TipRanks4 shared keywordsFinancial analysis and stock research platform.
Companies competing with Laplace Interventional for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$42M disclosed across 3 rounds · 2021–2025
▶$21.2MraisedFeb 2025 · 6 investors · Other Health CareRule 506(b)
▶$21.2MraisedFeb 2025 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jenny H. BarbaDirector
- Todd MortierDirector
- Colin MorrisonDirector
- Ramji IyerExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $21.2M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$12.9MraisedJul 2023 · 9 investors · Other Health CareRule 506(b)
▶$12.9MraisedJul 2023 · 9 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jenny BarbaDirector
- Ramji IyerExecutive Officer, Director
- Todd MortierDirector
- William DaiDirector
- Offering amount
- $12.9M
- Amount sold
- $12.9M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$7.9MraisedSep 2021 · 8 investors · Other Health CareRule 506(b)
▶$7.9MraisedSep 2021 · 8 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ramji IyerExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- Minimum investment
- $25K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Laplace Interventional do?
- Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
- Who founded Laplace Interventional?
- Laplace Interventional was founded by Ramji Iyer in 2020.
- Who are Laplace Interventional's investors?
- Laplace Interventional's investors include Aphelion Capital, gener8tor, ShangBay Capital LLC.
- How much funding has Laplace Interventional raised?
- Laplace Interventional has disclosed $42M raised across 3 rounds.
- Where is Laplace Interventional headquartered?
- Laplace Interventional is headquartered in Plymouth, US.